- Home
- CABO vs BEAM Comparison
CABO vs BEAM Comparison
Compare CABO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- BEAM
- Stock Information
- Founded
- CABO 1980
- BEAM 2017
- Country
- CABO United States
- BEAM United States
- Employees
- CABO N/A
- BEAM N/A
- Industry
- CABO Cable & Other Pay Television Services
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CABO Telecommunications
- BEAM Health Care
- Exchange
- CABO Nasdaq
- BEAM Nasdaq
- Market Cap
- CABO 2.0B
- BEAM 1.9B
- IPO Year
- CABO N/A
- BEAM 2020
- Fundamental
- Price
- CABO $366.05
- BEAM $24.70
- Analyst Decision
- CABO Hold
- BEAM Buy
- Analyst Count
- CABO 5
- BEAM 10
- Target Price
- CABO $554.40
- BEAM $47.67
- AVG Volume (30 Days)
- CABO 72.9K
- BEAM 1.1M
- Earning Date
- CABO 02-20-2025
- BEAM 02-25-2025
- Dividend Yield
- CABO 3.27%
- BEAM N/A
- EPS Growth
- CABO 847.26
- BEAM N/A
- EPS
- CABO 38.05
- BEAM N/A
- Revenue
- CABO $1,604,144,000.00
- BEAM $349,643,000.00
- Revenue This Year
- CABO N/A
- BEAM N/A
- Revenue Next Year
- CABO N/A
- BEAM $10.82
- P/E Ratio
- CABO $9.62
- BEAM N/A
- Revenue Growth
- CABO N/A
- BEAM 328.73
- 52 Week Low
- CABO $311.28
- BEAM $20.84
- 52 Week High
- CABO $574.53
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- CABO 41.82
- BEAM 41.30
- Support Level
- CABO $358.73
- BEAM $24.96
- Resistance Level
- CABO $372.49
- BEAM $29.52
- Average True Range (ATR)
- CABO 10.91
- BEAM 1.64
- MACD
- CABO -1.31
- BEAM -0.51
- Stochastic Oscillator
- CABO 44.24
- BEAM 9.71
About CABO Cable One Inc.
Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.